| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/01/2009 | US20090005539 Additives for the improved dewatering of corn gluten |
| 01/01/2009 | US20090005538 Apoptosis-Inducing Agent for Prostate Cancer Cells |
| 01/01/2009 | US20090005537 Process for constructing strain having compactin hydroxylation ability |
| 01/01/2009 | US20090005534 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005333 Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
| 01/01/2009 | US20090005317 Methods for treating a corneal disorder and promoting skin wound healing |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090005312 Novel glp-1 analogues linked to albumin-like agents |
| 01/01/2009 | US20090005311 Expression vector comprising nucleotide sequences coding fructooligosaccharide (FOS)-related protein for enhancing ability of probiotic bacteria to compete in the gastrointestinal tract of mammals |
| 01/01/2009 | US20090005308 activins (ActRIIB), for modulating (promoting or inhibiting) growth of tissue such as bone, cartilage, muscle, fat, and/or neuronal tissue; fusion proteins which inhibit signaling by myostatin and/or growth differentiation factor 11 in cell-based assay; drug screening; pharmacokinetics |
| 01/01/2009 | US20090005306 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005301 207 Human Secreted Proteins |
| 01/01/2009 | US20090005300 Antimicrobial Peptides and Methods of Use |
| 01/01/2009 | US20090005299 Method For Producing Carboxy-Terminal-Amidified Peptides |
| 01/01/2009 | US20090005298 Bone Sialoprotein Collagen-Binding Peptides |
| 01/01/2009 | US20090005297 Aprotinin Variants |
| 01/01/2009 | US20090005296 Ammonium/Ammonia Transporter |
| 01/01/2009 | US20090005295 Syndecans and angiogenesis |
| 01/01/2009 | US20090005294 Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors |
| 01/01/2009 | US20090004743 Helper virus-free aav production |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004719 Protein-protein interactions in human immunodeficiency virus |
| 01/01/2009 | US20090004696 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 01/01/2009 | US20090004693 Production of Polypeptides by Improved Secretion |
| 01/01/2009 | US20090004687 Predictive markers for ovarian cancer |
| 01/01/2009 | US20090004683 Indicator Agent for Noninflammatory Stress Response and Use Thereof |
| 01/01/2009 | US20090004676 T1R3 receptor binding assays for identification of taste modulatory compounds |
| 01/01/2009 | US20090004674 ACPL-related assays |
| 01/01/2009 | US20090004671 Marker Protein For Use In Diagnosis Of Pancreatic Cancer |
| 01/01/2009 | US20090004660 Method for detecting neuroblastoma and its malignancy and method for suppressing the same |
| 01/01/2009 | US20090004651 Screening methods for compounds that modulate the activity of G-protein coupled receptors |
| 01/01/2009 | US20090004278 Enzymatically Crosslinked Protein Nanoparticles |
| 01/01/2009 | US20090004251 Bacteriocins and Novel Bacterial Strains |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004226 Fusion proteins of mycobacterium tuberculosis |
| 01/01/2009 | US20090004225 Toxin compounds with enhanced membrane translocation characteristics |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004218 Antigen-Carbohydrate Conjugates |
| 01/01/2009 | US20090004216 inducing an immunological response in an animal by administering to the animal an attenuated CSFV pestivirus, wherein the RNase activity of glycoprotein ERNS of the CSFV pestivirus is inactivated by a deletion of the second histidine of the conserved ERNS sequence RHEWNKHGWCNW |
| 01/01/2009 | US20090004215 Chimeric G protein based rabies vaccine |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004205 Prospective identification and characterization of breast cancer stem cells |
| 01/01/2009 | US20090004203 Methods of treating measles infectious disease in mammals |
| 01/01/2009 | US20090004196 Method of inhibiting osteoclast activity |
| 01/01/2009 | US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004174 Fusion Proteins |
| 01/01/2009 | US20090004163 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/01/2009 | US20090004162 Hecgf-1 Related Polymorphisms and Applications Thereof |
| 01/01/2009 | US20090004160 Mass Producing Method of Growth Factor Using Adipose Derived Adult Stem Cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004144 Recombinant Adeno-Associated Virus Vector for Treatment of Alzheimer Disease |
| 01/01/2009 | US20090004111 Structure of the Hepatitis C Ns5a Protein |
| 12/31/2008 | WO2009003074A2 Cholinergic/serotoninergic chimeric receptor and uses thereof |
| 12/31/2008 | WO2009002981A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
| 12/31/2008 | WO2009002480A2 Acyl transferase having altered substrate specificity |
| 12/31/2008 | WO2009002366A1 Novel bacillus thuringiensis gene with lepidopteran activity |
| 12/31/2008 | WO2009002274A1 Cationic peptide for delivering an agent into a cell |
| 12/31/2008 | WO2009002198A2 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine |
| 12/31/2008 | WO2009002159A2 Intradermal hpv peptide vaccination |
| 12/31/2008 | WO2009001928A1 Peptide having hypotensive activity |
| 12/31/2008 | WO2009001867A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 12/31/2008 | WO2009001555A1 Expression controller of type i interferon |
| 12/31/2008 | WO2009001392A1 Gene codifying for ambra 1 protein which regulates autophagv and the development of the central nervous system |
| 12/31/2008 | WO2009001260A2 Cosmetic use of apolipoprotein d type proteins |
| 12/31/2008 | WO2009000957A1 Compositions for anti-fibrinolitic treatment |
| 12/31/2008 | WO2009000929A2 Composition and method for treatment of autoimmune disease |
| 12/31/2008 | WO2009000913A1 Fsh producing cell clone |
| 12/31/2008 | WO2009000891A2 Linear expression constructs for production of influenza virus particles |
| 12/31/2008 | WO2009000878A1 Kallikrein 7 modulators |
| 12/31/2008 | WO2009000876A1 Yield enhancement in plants by modulation of maize rp120-rna binding protein homolog (ebna2-coact) |
| 12/31/2008 | WO2009000848A1 Yield enhancement in plants by modulation of zmago1 |
| 12/31/2008 | WO2009000763A1 Process for purifying apyrogenic and virus-inactivated human hemoglobin |
| 12/31/2008 | WO2009000538A1 Trimeric death ligands with enhanced activity (tenascin) |
| 12/31/2008 | WO2009000137A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agnet, a method for modifying the agent and its use for manufacturing a medicament for treating tumor |
| 12/31/2008 | WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides |
| 12/31/2008 | WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/31/2008 | WO2009000066A1 Vaccine against clostridium perfringens |
| 12/31/2008 | WO2009000017A1 Peptides as antimicrobial agents towards campylobacter spp |
| 12/31/2008 | WO2008137471A3 Modified interferon beta polypeptides and their uses |
| 12/31/2008 | WO2008134640A3 Cells expressing chimeric ns4a proteins of hcv and their use in assays |
| 12/31/2008 | WO2008133873A9 Fgf-binding fusion proteins |
| 12/31/2008 | WO2008132568A3 Fusion proteins binding to growth factors |
| 12/31/2008 | WO2008129146A3 (3r)-hydroxyacyl-acp dehydratase enzymes involved in the biosynthesis of mycolic acids and use of same for screening antibiotics |
| 12/31/2008 | WO2008126065A3 Polynucleotides and polypeptides involved in gestational malaria, and biological applications |
| 12/31/2008 | WO2008125983A3 Methods of increasing plant growth |
| 12/31/2008 | WO2008118017A3 Prame derived peptides and immunogenic compositions comprising these |
| 12/31/2008 | WO2008116648A3 Novel glp-1 fusion peptides, their production and use |
| 12/31/2008 | WO2008112891A3 Monoclonal antibody that recognizes a seneca valley virus (svv) cellular receptor and uses thereof |
| 12/31/2008 | WO2008110868A3 Proliferated islets |
| 12/31/2008 | WO2008097585A3 Mutations in human ubiad1 |
| 12/31/2008 | WO2008096370A3 An efficient and novel purification method of recombinant hg-csf |
| 12/31/2008 | WO2008089074A3 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1 |
| 12/31/2008 | WO2008086025A3 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 12/31/2008 | WO2008084478A8 Anti-bacterial peptides and methods of treating diseases using same |
| 12/31/2008 | WO2008079545A3 Generation of plants with altered protein, fiber, or oil content |
| 12/31/2008 | WO2008075345A3 An apo-ferredoxin preparation, a process for producing same and uses thereof |
| 12/31/2008 | WO2008064094A3 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 12/31/2008 | WO2008063330A3 Molecular control of brown fat differentiation and energy expenditure |